Patents by Inventor Carl SAAB

Carl SAAB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260013779
    Abstract: A method of predicting a seizure occurrence or a surgical outcome includes monitoring a patient using an electroencephalography (EEG) system, including recording EEG data that indicates a seizure, and extracting a peri-ictal segment of the EEG data that includes a pre-ictal period immediately preceding the seizure, or a post-ictal period immediately following the seizure. The method also includes processing the peri-ictal segment, including generating an electrode-wise power spectral density (PSD) feature across a frequency band defined by at least one of a delta frequency range, a theta frequency range, an alpha frequency range, a beta frequency range, and a gamma frequency range. The method also includes inputting the PSD feature into a model, wherein the model predicts a seizure occurrence or a surgical outcome of the patient.
    Type: Application
    Filed: July 11, 2025
    Publication date: January 15, 2026
    Inventors: Shehryar R. Sheikh, Carl Saab, Lara Jehi
  • Patent number: 11064940
    Abstract: Disclosed are methods for detecting pain in a subject, such as a mammal (e.g., a human), using brain activity, e.g., as determined by electroencephalography. The methods are useful for treating or reducing the likelihood of pain in a subject by determining power amplitude from the power spectral density of the waveforms and, e.g., administering a therapeutic agent to the subject. The methods disclosed herein may also be utilized to screen for a therapeutic agent that decreases power amplitude using a non-human animal subject. The methods also feature the stimulation of thalamic reticular nucleus of a subject to treat or reduce pain.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: July 20, 2021
    Assignee: Rhode Island Hospital
    Inventor: Carl Saab
  • Patent number: 10835170
    Abstract: Disclosed are methods for detecting neuronal oscillation in the spinal cord of a subject. The methods can be utilized to determine that the subject has a disease or disorder of the spinal cord. The methods are useful for treating or reducing the likelihood of pain in a subject by detecting neuronal oscillation in the spinal cord and, e.g., administering a therapeutic agent to the subject. The electrode (LFP) methods disclosed herein may also be utilized to screen for a therapeutic agent that decreases neuronal oscillation in the spinal cord using a non-human animal subject.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: November 17, 2020
    Assignee: Rhode Island Hospital
    Inventor: Carl Saab
  • Publication number: 20180228421
    Abstract: Disclosed are methods for detecting neuronal oscillation in the spinal cord of a subject. The methods can be utilized to determine that the subject has a disease or disorder of the spinal cord. The methods are useful for treating or reducing the likelihood of pain in a subject by detecting neuronal oscillation in the spinal cord and, e.g., administering a therapeutic agent to the subject. The electrode (LFP) methods disclosed herein may also be utilized to screen for a therapeutic agent that decreases neuronal oscillation in the spinal cord using a non-human animal subject.
    Type: Application
    Filed: August 11, 2016
    Publication date: August 16, 2018
    Inventor: Carl SAAB
  • Publication number: 20170311882
    Abstract: Disclosed are methods for detecting pain in a subject, such as a mammal (e.g., a human), using brain activity, e.g., as determined by electroencephalography. The methods are useful for treating or reducing the likelihood of pain in a subject by determining power amplitude from the power spectral density of the waveforms and, e.g., administering a therapeutic agent to the subject. The methods disclosed herein may also be utilized to screen for a therapeutic agent that decreases power amplitude using a non-human animal subject. The methods also feature the stimulation of thalamic reticular nucleus of a subject to treat or reduce pain.
    Type: Application
    Filed: April 28, 2017
    Publication date: November 2, 2017
    Inventor: Carl SAAB